Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.48M$1.48Mderivedno prior Q4 2024 on file Net Income$1.03M$1.03MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,143,421— Operating Incomederived$1,029,627+26,636.6% Operating Cash Flowderived$1,241,052+193.3% Margins · derivedGross margin77.3%
Operating margin69.6%
Net margin69.6%
ended Dec 31, 2025 · filed Mar 27, 2026 · 86 d after period end